Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Modern Chinese Medicine Group Co., Ltd. announces its subscription results 2021-01-14 14:30
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference 2021-01-14 09:32
ATIF Holdings Limited Announces Its IPO Client Soars 100% in the U.S. Trading Debut 2021-01-13 21:00
China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL 2021-01-13 21:00
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine) 2021-01-13 09:00
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab injection) as First-Line Therapy in Hepatocellular Carcinoma (HCC) 2021-01-13 08:00
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-12 22:57
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer 2021-01-12 17:26
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41 2021-01-12 08:30
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
Regent Pacific Announces Key Research Findings On FORTACIN™ 2021-01-11 23:36
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma 2021-01-11 22:00
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA. 2021-01-11 11:33
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-11 07:26
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients 2021-01-10 16:55
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 2021-01-09 11:06
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis 2021-01-08 20:55
Gracell Biotechnologies Announces Pricing of Initial Public Offering 2021-01-08 14:55
Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho 2021-01-08 14:00
1 263 264 265 266 267 412